Scarica l'app Stockscreener
6.816
4.54%
-0.324
Neuphoria Therapeutics Inc Borsa (NEUP) Ultime notizie
Neuphoria to Present at the American Society of Clinical Psychop - GuruFocus
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting | NEUP Stock News - GuruFocus
Neuphoria Therapeutics to Present BNC210 Phase 2b Data at ASCP 2025 Annual Meeting - Nasdaq
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting - GlobeNewswire
Neuphoria Provides First Quarter 2025 Business Updates | NEUP St - GuruFocus
Neuphoria Therapeutics Inc. Reports Q1 2025 Progress and Upcoming Milestones for BNC210 and MK-1167 Programs - Nasdaq
Neuphoria Provides First Quarter 2025 Business Updates - GlobeNewswire
Neuphoria Therapeutics Says Cash Runway Extends Into Q3 2026SEC Filing - marketscreener.com
Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView
Neuphoria Therapeutics Delays 10-Q Filing - TipRanks
Neuphoria Therapeutics (NEUP) Outlines Robust 2025 Drug Developm - GuruFocus
Neuphoria Therapeutics IncMerck Pays $15M Milestone, Extends Cash Runway To Q3 2026 - marketscreener.com
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans - GlobeNewswire
Neuphoria receives $15M milestone payment from Merck - MSN
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025 - GlobeNewswire
Neuphoria Therapeutics Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Neuphoria Therapeutics Inc Rings the Opening Bell - Nasdaq
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes - MSN
Neuphoria Therapeutics’ Listing on Nasdaq - Global Legal Chronicle
Neuphoria Therapeutics Inc. (NEUP) reports earnings - Quartz
Neuphoria Therapeutics rises on $15 mln milestone payment from Merck - TradingView
Neuphoria Therapeutics shares surge on $15M Merck payment - MSN
Neuphoria To Receive $15 Mln Milestone Payment From Merck; Stock Up In Pre-market - Nasdaq
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - GlobeNewswire
Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN
Neuphoria Therapeutics shares surge on $15M Merck payment By Investing.com - Investing.com Australia
Here's Why Momentum in Neuphoria Therapeutics Inc. (NEUP) Should Keep going - MSN
Neuphoria Therapeutics Takes the Biotech Spotlight: U.S. Relocation and Nasdaq Debut Promise Game-Changing Opportunities - Jomfruland.net
Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Given New $21.00 Price Target at HC Wainwright - Armenian Reporter
Brokers Set Expectations for NEUP Q2 Earnings - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Stock - Defense World
FY2027 Earnings Estimate for NEUP Issued By HC Wainwright - Defense World
Why Neuphoria Therapeutics Inc. (NEUP) Surged on Friday - MSN
10 Firms Defy Market Pessimism - Insider Monkey
Stock market news: Nvni Group +254.36%, Allurion Technologies +153.92% among top gainers during mid day trading - Business Upturn
Stock market news: Neuphoria Therapeutics and Nvni Group saw surge of 134.96% and 245.64% concurrently during mid day trading - Business Upturn
Neuphoria Therapeutics regains Nasdaq compliance - Investing.com India
Neuphoria Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Australia
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder - Marketscreener.com
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):